HR 747 (116th Congress) would direct the Department of Veterans Affairs (VA) to support and oversee research regarding the efficacy and safety of medicinal cannabis on health outcomes relating to chronic pain, post-traumatic stress disorder, and other conditions of certain ‘covered veterans.’ The term ‘covered veterans’ is defined as “a veteran who is enrolled in the patient enrollment system of the Department of Veterans Affairs under section 1705 of title 38, United States Code”.
Before beginning studies, the VA would be required to submit a plan for implementation and requests for proposals to both the House and Senate Committees on Veterans’ Affairs. The bill specifies that the VA could study various forms of cannabis including full plants and extracts, several strains of cannabis, and different types of tetrahydrocannabinol. Various methods of cannabis delivery (e.g., topical application, inhalation, and ingestion) could also be studied. The bill’s authors specify that the VA would be required to submit annual reports describing the research to the House and Senate Committees on Veterans’ Affairs for the five-year period following enactment of the Act. All data collected would be preserved in such a way to facilitate further, future research.